UK small-cap RNS · 3 Aug 2026

Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.

Key = all announcements except routine filings (voting rights, buybacks, holdings, director forms), plus the ones that are part of a situation. Not investment advice.

Sort: Newest · Largest companies

07:00

Chrysalis Investments Limited CHRY £295m
Quarterly NAV Announcement and Trading Update Trading update
NAV per share slipped 2.1% to 131.09p, the third straight quarterly fall, as Starling's carrying value dropped 5% on peer valuations. Deep Instinct was fully written down and wefox took an uncertainty discount.

Disposal of a part (break-up) outlook mixed +0.7% on the day

Moved: Maintain a cash buffer of up to £50m: pending → changed – The cash buffer has run down to £1.0m gross cash, and Klarna shares are being sold to fund working capital. · Klarna IPO lock-up: Partial sale done; residual holding $75.6m → Further Klarna sales funding working capital · Shareholder consultation and structural review: Orderly realisation under way; self-managed handover → Debt repaid; handover to self-management imminent
07:00

Elixirr International ELIX £243m
Trading Update and Appointment of Joint Broker Trading update
Elixirr International plc (ELIX.L), an established global, award-winning challenger consultancy, is pleased to provide a trading update following the end of the six-month period ended 30 June 2026 ("H1 26").

+1.9% on the day
07:00

Microlise Group SAAS £75m
H1 FY26 Trading Update Trading update
The Board only confirms FY26 EBITDA in line with consensus (£10m-£11.1m). It is not a raise, but it follows May's guidance of the lower end of expectations and revenue slightly below.

Turnaround plan with targets £20.0m · 27% of mcapin lineoutlook mixedfirst since Oct 2023 +0.0% on the day

Moved: OEM customer order weakness: Early signs of stabilisation; FY26 still lower → OEM ARR down to £13.7m; still weak · Delayed UK customer projects: Projects progressing; revenue due in FY26 → Still delayed by component shortages · Accelerated FY26 investment programme: Announced; FY26 spend weighs on EBITDA → Progressing to plan; margin 13.2%